Position in IMRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$49,900
-$2,800 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 111 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $4,203,874 across 8 Biotechnology names. IMRX ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,390 | $1,683,914 | |
| 2 | MRNA |
Moderna, Inc.
|
14,616 | $1,023,558 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,330 | $570,314 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
645 | $402,183 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
6,732 | $367,163 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
19,550 | $71,748 | |
| 7 | IMRX |
Immuneering Corp
This page
|
10,000 | $49,900 | |
| 8 | NGEN |
Nervgen Pharma Corp.
|
17,036 | $35,094 |
All Filings in IMRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,900 | 10,000 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $52,700 | 10,000 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $65,800 | 10,000 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $77,000 | 11,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||